BioMarin Pharmaceuticals, Inc. (BMRN) Tops Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $66.12 +1.61%
Financial Fact:
Collaborative agreement revenues: 1K
Today's EPS Names:
SQZB, ARDS, MDRX, More
Financial Fact:
Collaborative agreement revenues: 1K
Today's EPS Names:
SQZB, ARDS, MDRX, More
Join SI Premium – FREE
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) reported Q3 EPS of $0.04, $0.14 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $113.4 million versus the consensus estimate of $113.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Misses Q4 EPS; Offers FY27 Guidance
- Semtech (SMTC) Tops Q2 EPS by 10c, Beats on Revenue; Offers Q3 Guidance
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
